Bonnie Dighero-Kemp
Overview
Explore the profile of Bonnie Dighero-Kemp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1081
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fallah M, Van Ryn C, Moses J, Badio M, Fayiah T, Johnson K, et al.
Lancet Microbe
. 2025 Mar;
:101033.
PMID: 40081398
Background: A high proportion of survivors of Ebola virus disease (EVD) have post-acute sequelae of EVD (PASE), but the relationship between inflammation and PASE pathogenesis is poorly understood. This study...
2.
Davey Jr R, Collins G, Rouphael N, Poliquin G, McConnell R, Grubbs G, et al.
Lancet Microbe
. 2024 Oct;
5(11):100923.
PMID: 39374605
Background: rVSVΔG-ZEBOV-GP is the first approved vaccine with clinical efficacy against Ebola virus disease. Although a seroprotective threshold has not been defined for those at occupational risk of exposure, the...
3.
Fallah M, Reilly C, Van Ryn C, Badio M, Camanor S, Kaler S, et al.
Lancet Glob Health
. 2023 Jun;
11(7):e1053-e1060.
PMID: 37349033
Background: Minimal data exist on pregnancy following recovery from Ebola in people of child-bearing potential (females aged roughly 18-45 years). The aim of this study was to assess viral persistence...
4.
Kieh M, Richert L, Beavogui A, Grund B, Leigh B, DOrtenzio E, et al.
N Engl J Med
. 2022 Dec;
387(26):2411-2424.
PMID: 36516078
Background: Questions remain concerning the rapidity of immune responses and the durability and safety of vaccines used to prevent Zaire Ebola virus disease. Methods: We conducted two randomized, placebo-controlled trials...
5.
Kelly J, Frankfurter R, Tavs J, Barrie M, McGinnis T, Kamara M, et al.
Open Forum Infect Dis
. 2022 Mar;
9(4):ofac052.
PMID: 35265726
Background: It remains unclear if there is a dose-dependent relationship between exposure risk to Ebola virus (EBOV) and severity of illness. Methods: From September 2016 to July 2017, we conducted...
6.
Hoff N, Bratcher A, Kelly J, Musene K, Kompany J, Kabamba M, et al.
Proc Natl Acad Sci U S A
. 2022 Feb;
119(6).
PMID: 35110410
Despite more than 300,000 rVSVΔG-ZEBOV-glycoprotein (GP) vaccine doses having been administered during Ebola virus disease (EVD) outbreaks in the Democratic Republic of the Congo (DRC) between 2018 and 2020, seroepidemiologic...
7.
Iglesias A, Periolo N, Bellomo C, Lewis L, Olivera C, Anselmo C, et al.
EBioMedicine
. 2022 Jan;
75:103765.
PMID: 34986457
Background: The hallmarks of HPS are increase of vascular permeability and endothelial dysfunction. Although an exacerbated immune response is thought to be implicated in pathogenesis, clear evidence is still elusive....
8.
Jiang S, Mukherjee N, Bennett R, Chen H, Logue J, Dighero-Kemp B, et al.
Front Immunol
. 2021 Dec;
12:729845.
PMID: 34938283
Non-human primate (NHP) animal models are an integral part of the drug research and development process. For some biothreat pathogens, animal model challenge studies may offer the only possibility to...
9.
Bozman C, Fallah M, Sneller M, Freeman C, Fakoli 3rd L, Shobayo B, et al.
Emerg Infect Dis
. 2021 Mar;
27(4):1239-1241.
PMID: 33755000
Ebola virus RNA can reside for months or years in semen of survivors of Ebola virus disease and is probably associated with increased risk for cryptic sexual transmission of the...
10.
Eghrari A, Shantha J, Ross R, Van Ryn C, Crozier I, Hayek B, et al.
Transl Vis Sci Technol
. 2021 Feb;
10(1):32.
PMID: 33520427
Purpose: In survivors of Ebola virus disease (EVD), intraocular viral persistence raises questions about the timing and safety of cataract surgery. To the best of our knowledge, this is the...